J. Tinoco

发表

Relative Efficacy of AS03-Adjuvanted Pandemic Influenza A(H1N1) Vaccine in Children: Results of a Controlled, Randomized Efficacy Trial

D. Vaughn, Ping Li, L. Fries, 2014, The Journal of infectious diseases.

Nosocomial bacteremia and urinary tract infections caused by extended-spectrum beta -lactamase-producing Klebsiella pneumoniae with plasmids carrying both SHV-5 and TLA-1 genes.

C. Alpuche-Aranda, J. Santos, J. Tinoco, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Virulence and antibiotic resistance of Enterococcus faecalis clinical isolates recovered from three states of Mexico. Detection of linezolid resistance.

J. Tinoco, E. Rodriguez-Noriega, R. Morfín-Otero, 2013, Archives of medical research.

Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: a phase III, randomized trial.

W. Dewé, B. Innis, A. Cruz-Valdéz, 2014, Vaccine.

Relative Ef ﬁ cacy of AS03-Adjuvanted Pandemic In ﬂ uenza A(H1N1) Vaccine in Children: Results of a Controlled, Randomized Ef ﬁ cacy Trial

D. Vaughn, Ping Li, L. Fries, 2014 .

Outbreak of nosocomial sepsis and pneumonia in a newborn intensive care unit by multiresistant extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: high impact on mortality.

C. Alpuche-Aranda, J. Santos, J. Tinoco, 2001, Infection control and hospital epidemiology.

Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials.

Shinn-Jang Hwang, L. Cámpora, E. Ledent, 2019, Vaccine.

Relative Ef fi cacy of AS 03-Adjuvanted Pandemic In fl uenza A ( H 1 N 1 ) Vaccine in Children : Results of a Controlled , Randomized Ef fi cacy Trial

D. Vaughn, Ping Li, L. Fries, 2014 .

Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study

T. Vesikari, L. Weiner, N. Klein, 2019, Journal of the Pediatric Infectious Diseases Society.

Clinical and Bacteriologic Efficacy of Amoxycillin b.d. (45 mg/kg/day) Versus Amoxycillin t.d.s (40 mg/kg/day) in Children with Group A b-hemolytic Streptococcal Tonsillopharyngitis

L. Huicho, Z. Bhutta, J. Tinoco, 2000, Journal of chemotherapy.

Antimicrobial susceptibility of gram-negative bacilli isolated from intra-abdominal and urinary-tract infections in Mexico from 2009 to 2015: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)

J. Sifuentes-Osornio, J. Tinoco, E. Rodriguez-Noriega, 2018, PloS one.

Abstracts presented at the 26th Annual Congress of the Belgian Society of Internal Medicine, 9-10 December 2022, Dolce La Hulpe, La Hulpe, Belgium

N. Trotta, J. Yombi, Oriol Calvete, 2022, Acta Clinica Belgica.

The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70

A. Schaefer, Shinn-Jang Hwang, G. Icardi, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

8. The Adjuvanted Recombinant Zoster Vaccine (RZV) Confers Long-term Protection Against Herpes Zoster: Interim Results of an Extension Study (ZOSTER-049) of Two Clinical Trials (ZOE-50 and ZOE-70)

Chong-Jen Yu, A. Schuind, J. Díez-Domingo, 2020, Open Forum Infectious Diseases.

Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.

T. Vesikari, G. Ruiz-Palacios, T. Breuer, 2006, The New England journal of medicine.

Respiratory viruses and influenza-like illness: Epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample

D. Vaughn, Ping Li, E. Lazcano-Ponce, 2016, Journal of Infection.

Species distribution and antifungal susceptibility of bloodstream fungal isolates in paediatric patients in Mexico: a nationwide surveillance study.

N. León-Sicairos, A. Bonifaz, J. Tinoco, 2013, The Journal of antimicrobial chemotherapy.

Outbreak of Nosocomial Sepsis and Pneumonia in a Newborn Intensive Care Unit by Multiresistant Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae High Impact on Mortality

C. Alpuche-Aranda, J. Santos, J. Tinoco, 2001, Infection Control & Hospital Epidemiology.

Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains isolated from invasive and non-invasive infections from Mexico and the USA during 1999-2010.

J. Śanchez-Corona, D. Stevens, A. Bryant, 2012, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination

Hyo Youl Kim, Kenjiro Nakamura, A. Schaefer, 2022, Open forum infectious diseases.

Prevalence and Incidence of Respiratory Syncytial Virus and Other Respiratory Viral Infections in Children Aged 6 Months to 10 Years With Influenza-like Illness Enrolled in a Randomized Trial

D. Vaughn, Ping Li, E. Lazcano-Ponce, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Bacterial incidence and drug resistance from pathogens recovered from blood, cerebrospinal and pleural fluids in 2019–2020. Results of the Invifar network

Alejandro Molina, Araceli Arancha García-del Soto, A. Camacho-Ortíz, 2023, PeerJ.

[Epidemiology of nosocomial infections in a second level hospital].

J. Tinoco, M. C. Perez-Prado, J. Salvador-Moysén, 1997, Salud publica de Mexico.

Open-Label Trial of Immunogenicity and Safety of a 13-Valent Pneumococcal Conjugate Vaccine in Adults ≥50 Years of Age in Mexico

W. Gruber, J. Tinoco, D. Scott, 2014, Clinical and Vaccine Immunology.

Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults

H. Nell, T. Mzolo, Y. Kovshirina, 2021, Human vaccines & immunotherapeutics.

Endemicity of Pseudomonas aeruginosa producing IMP-18 and/or VIM-2 MBLs from the high-risk clone ST111 in Central America

M. Castanheira, J. Tinoco, L. Deshpande, 2023, JAC-antimicrobial resistance.

Open-Label Trial of Immunogenicity and Safety of a 13-Valent Pneumococcal Conjugate Vaccine in Adults ≥50 Years of Age in Mexico

W. Gruber, J. Tinoco, D. Scott, 2014, Clinical and Vaccine Immunology.